Photic responses in "minimal brain dysfunction".

Suppr

超能文献

作者信息

Milstein V, Small J G

机构信息

Indiana University Medical Center, Larue D. Carter Memorial Hospital, Indianapolis 46260, USA.

出版信息

Dis Nerv Syst. 1974 Aug;35(8):355-7.

PMID:17894071

Abstract

摘要

相似文献

Photic responses in "minimal brain dysfunction".

Dis Nerv Syst. 1974 Aug;35(8):355-7.

Pemoline in ADHD.

J Am Acad Child Adolesc Psychiatry. 1997 Dec;36(12):1649-50. doi: 10.1097/00004583-199712000-00007.

Compliance with FDA recommendations for pemoline.

J Am Acad Child Adolesc Psychiatry. 2003 Apr;42(4):383; author reply 383. doi: 10.1097/01.CHI.0000037045.04952.A0.

Medication for attention deficit hyperactivity disorder: commentary and response.

J Am Coll Health. 1996 Jul;45(1):40-1; discussion 41-2. doi: 10.1080/07448481.1996.9937544.

Pemoline (Cylert): market withdrawal.

CMAJ. 2000 Jan 11;162(1):106, 110.

The neurology of attention deficit/hyperactivity disorder.

Brain Dev. 2005 Dec;27(8):541-3. doi: 10.1016/j.braindev.2005.02.003.

Coming into focus. Pharmacologic treatment for ADHD.

Adv NPs PAs. 2010 Dec;1(4):16-22; quiz 23.

Pharmacological treatment of attention deficit disorder, residual type (ADD,RT, "minimal brain dysfunction," "hyperactivity") in adults.

Psychopharmacol Bull. 1985;21(2):222-31.

Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects.

Biol Psychiatry. 2008 May 15;63(10):917-26. doi: 10.1016/j.biopsych.2007.11.022. Epub 2008 Feb 13.

Pemoline (Cylert) for minimal brain dysfunction.

Med Lett Drugs Ther. 1976 Jan 16;18(2):5-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Photic responses in "minimal brain dysfunction".

Dis Nerv Syst. 1974 Aug;35(8):355-7.

Pemoline in ADHD.

J Am Acad Child Adolesc Psychiatry. 1997 Dec;36(12):1649-50. doi: 10.1097/00004583-199712000-00007.

Compliance with FDA recommendations for pemoline.

J Am Acad Child Adolesc Psychiatry. 2003 Apr;42(4):383; author reply 383. doi: 10.1097/01.CHI.0000037045.04952.A0.

Medication for attention deficit hyperactivity disorder: commentary and response.

J Am Coll Health. 1996 Jul;45(1):40-1; discussion 41-2. doi: 10.1080/07448481.1996.9937544.

Pemoline (Cylert): market withdrawal.

CMAJ. 2000 Jan 11;162(1):106, 110.

The neurology of attention deficit/hyperactivity disorder.

Brain Dev. 2005 Dec;27(8):541-3. doi: 10.1016/j.braindev.2005.02.003.

Coming into focus. Pharmacologic treatment for ADHD.

Adv NPs PAs. 2010 Dec;1(4):16-22; quiz 23.

Pharmacological treatment of attention deficit disorder, residual type (ADD,RT, "minimal brain dysfunction," "hyperactivity") in adults.

Psychopharmacol Bull. 1985;21(2):222-31.

Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects.

Biol Psychiatry. 2008 May 15;63(10):917-26. doi: 10.1016/j.biopsych.2007.11.022. Epub 2008 Feb 13.

Pemoline (Cylert) for minimal brain dysfunction.

Med Lett Drugs Ther. 1976 Jan 16;18(2):5-6.